About this trial
The purpose of this study is to describe the population pharmacokinetic characteristics in patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy, and to evaluate effectiveness and safety of these drugs.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy.
Disqualifiers
Pregnant/lactating women.
There are other factors that the researchers think are not suitable for inclusion
Trial population
Patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy.
Trial design
Cohort
Prospective
Treatments tested in this trial
Anti-Infective Drugs
DrugAnti-infective drugs are administered using the traditional clinical dosing regimen, with no interventions.
Treatment groups
Trial outcomes
Primary outcomes
Clearance (L/h)
Volume of Distribution (L)
Secondary outcomes
the ratio of the area under the concentration-time curve from 0 to 24 hours
For time-dependent antimicrobials, the PD target is defined as the time of free drug concentration beyond MIC during the dose interval. For concentration-dependent antimicrobials, the PD target is defined as the ratio of the area under the concentration-time curve from 0 to 24 hours to the MIC.
erythrocyte sedimentation rate
Clinical treatment outcome
Adverse events
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Shandong University
Lead sponsor
Shandong Public Health Clinical Center
Collaborator